27 April 2026 - trading update
The independent provider of NHS funded surgical procedures has announced a trading update for the financial year to 31 March 2026 which has revealed that trading has been strong towards the end of the year so that the results for the year will come in above market expectations. Revenue for the year is expected to be £32m, a useful increase on our forecast of £29.6m and adjusted pre-tax profits are likely to be around £2.45m for earnings per share of around 13.2p. Our forecast was for £2.3m and 12.4p . . .
This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.
Already a member, log in HERE.
